tirzepatide latest news FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now FDA says the tirzepatide weight-loss

And while most of these compounds start off being tested and approved for type-2 diabetes, and later are tested and approved specifically for obesity, that order may be changing

Related Reading Can A Genetic Test Show If I Have An Increased Risk For Kidney Disease What Determines If You Are A Morning Person Or A Night Owl What Are The Genetic Factors Impacting Heart Health And Reducing Heart Disease Risk What Are The Genetic Risk Factors For Addisons Disease And Role Of Personalized Health Reports Pricing and availability current as of June 2026

Eat smaller meals plus snacks GLP-1 drugs can reduce your appetite which may affect your energy levels

The risk groups of patients were low-risk in 13 (8.0%), intermediate-risk in 47 (29.0%), high-risk in 75 (46.3%), and locally advanced disease in 27 patients (16.7%)